Jonathan E. Golub

powered by
COS Expertise®
Johns Hopkins University
School of Medicine
Infectious Diseases
Assistant ProfessorAppointed: 2003
Johns Hopkins University
Bloomberg School of Public Health
Epidemiology
Assistant ProfessorAppointed: 2003

Mailing Address

1550 Orleans St.
1M.07
Baltimore, Maryland 21231
United States

Contact Information

Phone: (443) 287-2969
Fax: (410) 955-0740
jgolub@jhmi.edu

Qualifications

Ph.D., Johns Hopkins University, Infectious Disease Epidemiolgy, 2003.
M.P.H., Columbia University, Epidemiology, 1996.
B.A., State University of New York at Binghamton, Biology & History, 1993.

Expertise and Research Interests

My primary research focus has been in the epidemiology of tuberculosis, primarily in the context of HIV infection. I am currently a co-investigator on two large scale community randomized trials in Brazil. I conduct research in South Africa as well, focusing on HIV-infected patients and tuberculosis and their interaction with tobacco.

In addition, since 2005, I have been the primary instructor for the Epidemiologic Basis for Tuberculosis Control, a class developed and co-instructed by the late Professor Emeritus, Dr. George W. Comstock. This course is conducted thrice-yearly, both in class and online as part of the distance education program at Johns Hopkins University. I have also developed a one-year training course for Brazilian clinicians and epidemiologists emphasizing methods in developing, implementing and analyzing epidemiologic studies. This course is in its second year and will expand to include South African participants in 2008.

Keywords

COS Keywords:

Clinical Trial, Epidemiology, Infectious Diseases Or Agents, Tuberculosis.

Additional Terms:

Clinical Trials, Epidemiology, Infectious Diseases, Tuberculosis.

Publications

  • Luquero FJ, Sanchez-Padilla E, Simon-Soria F, Eiros JM, Golub JE (Feb 2008) Trend and seasonality of tuberculosis in Spain, 1996-2004., The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 12 (2), 221-4 Abstract
  • Rabizadeh S, Rhee KJ, Wu S, Huso D, Gan CM, Golub JE, Wu X, Zhang M, Sears CL (Dec 2007) Enterotoxigenic bacteroides fragilis: a potential instigator of colitis., Inflammatory bowel diseases, 13 (12), 1475-83 Abstract
  • Panjabi R, Comstock GW, Golub JE (Aug 2007) Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk., The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 11 (8), 828-37 Abstract
  • Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B (Jul 2007) The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil., AIDS (London, England), 21 (11), 1441-8 Abstract
  • Bastos LG, Fonseca LS, Mello FC, Ruffino-Netto A, Golub JE, Golub JL, Conde MB (Feb 2007) Prevalence of pulmonary tuberculosis among respiratory symptomatic subjects in an out-patient primary health unit., The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 11 (2), 156-60 Abstract
  • Moulton LH, Golub JE, Durovni B, Cavalcante SC, Pacheco AG, Saraceni V, King B, Chaisson RE (2007) Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention., Clinical trials (London, England), 4 (2), 190-9 Abstract
  • Golub JE, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, Chaisson RE (Jan 2006) Delayed tuberculosis diagnosis and tuberculosis transmission., The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 10 (1), 24-30 Abstract
  • Golub JE, Mohan CI, Comstock GW, Chaisson RE (Nov 2005) Active case finding of tuberculosis: historical perspective and future prospects., The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 9 (11), 1183-203 Abstract
  • Golub JE, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, Chaisson RE (Sep 2005) Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence state, The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease, 9 (9), 992-8
  • Golub JE, Bur S, Cronin WA, Gange S, Sterling TR, Oden B, Baruch N, Comstock GW, Chaisson RE (Apr 2005) Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis, The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease, 9 (4), 392-7
  • Bur S, Golub JE, Armstrong JA, Myers K, Johnson BH, Mazo D, Fielder JF, Rutz H, Maltas G, McClain R, Cronin WA, Baruch NG, Barker LF, Benjamin W, Sterling TR (Dec 2003) Evaluation of an extensive tuberculosis contact investigation in an urban community and jail, The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease, 7 (12 Suppl 3), S417-23
  • Cronin WA, Golub JE, Lathan MJ, Mukasa LN, Hooper N, Razeq JH, Baruch NG, Mulcahy D, Benjamin WH, Magder LS, Strickland GT, Bishai WR (Nov 2002) Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough?, Emerging Infectious Diseases, 8 (11), 1271-9
  • Lathan M, Mukasa LN, Hooper N, Golub J, Baruch N, Mulcahy D, Benjamin W, Cronin WA (Nov 2002) Cross-jurisdictional transmission of Mycobacterium tuberculosis in Maryland and Washington, D C, 1996-2000, linked to the homeless, Emerging Infectious Diseases, 8 (11), 1249-51
  • Chaisson RE, Armstrong J, Stafford J, Golub J, Bur S, Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners, Jama : the Journal of the American Medical Association, 288(2), 165-6, Jul 2002
  • Dooley KE, Golub J, Goes FS, Merz WG, Sterling TR (Jun 2002) Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis, Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 34 (12), 1607-12
  • Golub JE, Cronin WA, Obasanjo OO, Coggin W, Moore K, Pope DS, Thompson D, Sterling TR, Harrington S, Bishai WR, Chaisson RE (Oct 2001) Transmission of Mycobacterium tuberculosis through casual contact with an infectious case, Archives of Internal Medicine, 161 (18), 2254-8
  • Cronin WA, Golub JE, Magder LS, Baruch NG, Lathan MJ, Mukasa LN, Hooper N, Razeq JH, Mulcahy D, Benjamin WH, Bishai WR (Oct 2001) Epidemiologic usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110, Journal of Clinical Microbiology, 39 (10), 3709-11
  • Golub JE, Haselow DT, Hageman JC, Lopez AS, Oldach DW, Grattan LM, Perl TM (May 1998) Pfiesteria in Maryland: preliminary epidemiologic findings, Maryland Medical Journal (baltimore, Md. : 1985), 47 (3), 137-43
  • Perl TM, Golub JE (Jan 1998) New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage, The Annals of Pharmacotherapy, 32 (1), S7-16

Profile Details

Last Updated: 3/6/2008

COS Expertise ID #1230319
Reference this profile directly: http://myprofile.cos.com/jgolub